Thoracic Aortic Dissection
16
3
9
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (16)
MBA Early Feasibility Study
Pathogenetic Basis of Aortopathy and Aortic Valve Disease
Thoraflex Hybrid and Relay Extension Post-Approval Study
Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients
Real-world Study on Fenestrated Stent for Thoracic Aortic Dissection
DISSECT-N Post Market Data Collection Registry
Impact of Right Atrial Occlusion on TEVAR Outcomes
Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY（PATENCY）
Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System
Quick Yielding Modified Short-Distance Fenestration Technique for the Treatment of Complex Aortic Arch Diseases: a Multicenter Single-Arm Objective Performance Criteria Trial(QYM-Tech Study)
CTAG Dissection/Trauma Post Marketing Surveillance Japan
Post-market Clinical Trial of the Dominus® Stent-Graft
Thrombosomes® in Acute Thoracic Aortic Dissections
Trial of Exercise in Aortic Dissection Survivors
Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions
ENDOBARC-S Study: "Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain"